CRYO ROP PARTICIPATING CENTER--PHASE III
CRYO ROP 参与中心--第三期
基本信息
- 批准号:2430377
- 负责人:
- 金额:$ 1.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-06-01 至 1998-05-31
- 项目状态:已结题
- 来源:
- 关键词:child (0-11) color visions cooperative study cryotherapy disease /disorder proneness /risk eye disorder diagnosis human subject human therapy evaluation longitudinal human study low birth weight infant human pediatrics perimetry premature infant human retinopathy of prematurity vision disorders visual fields visual perception
项目摘要
DESCRIPTION (Investigator's Abstract)
The purpose of the proposed study is to examine the long-term structural
and functional effects of cryotherapy as a treatment for severe
retinopathy of prematurity (ROP). In the initial phase of the study,
eyes with 5 contiguous or 8 total clock hours of stage 3 plus ROP, in
291 infants with birth weights less than 1251 g., were randomized to
received cryotherapy or no cryotherapy. Follow-up to age 12 months
indicated that cryotherapy reduced the incidence of unfavorable
structural outcome by 45.8 percent, and the incidence of unfavorable
visual acuity outcome by 37.8 percent. Based on the preliminary data,
follow-up to age 42 months during Phase II of the study indicated that
cryotherapy reduced the incidence of unfavorable resolution acuity
outcome by 21.4 percent, and by 19.7 percent when based on measurement
of recognition acuity.
The present study proposes to follow patients in the randomized group and
a relatively small subgroup (67) of potentially high risk patients from
the Natural History study through age 10 years, to determine whether the
reduction in benefit of cryotherapy noted between ages 12 and 42 months
continues into mid-childhood.
Evaluation of the effects of cryotherapy will be based on examination
findings in the posterior pole of the eye and on assessment of visual
acuity, as in Phase II. In addition, a more complete evaluation of
visual function will be conducted at age 9 years, through assessment of
monocular contrast sensitivity, monocular color vision, and stereopsis,
and at age 10 years, through measurement of the extent of the visual
field by Goldmann perimetry.
描述(研究者摘要)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen S. Feman其他文献
Serum angiotensin converting enzyme in diabetic patients.
糖尿病患者血清血管紧张素转换酶。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:3.1
- 作者:
Stephen S. Feman;Robert A. Mericle;George W. Reed;James M. May;Robert J. Workman - 通讯作者:
Robert J. Workman
Stephen S. Feman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}